$MDT (Medtronic plc)

$MDT {{ '2016-04-21T15:58:49+0000' | timeago}} • Announcement

$MDT announced the launch of the new Barrx 360 Express radiofrequency ablation (RFA) balloon catheter, which can help in the treatment of Barrett's esophagus. The Barrx 360 Express catheter, with its self-adjusting circumferential RFA catheter, lets gastroenterologists and surgeons provide RFA treatment more easily and efficiently.

$ISRG {{ '2017-10-19T21:40:26+0000' | timeago}} • Announcement

Worldwide da Vinci procedures grew approx. 15% in 3Q17 as $ISRG shipped 169 da Vinci Surgical Systems during the quarter. With $TRXC already in its sight, Intuitive Surgical will also be eyeing $MDT with much more concern as Medtronic is set to roll out its surgical robot system next year.

$MDT {{ '2017-10-16T20:09:05+0000' | timeago}} • Announcement

$MDT said its Medtronic Care Management Services (MCMS) business and American Well entered into a strategic partnership. Under the agreement, the businesses will work together to enable patient access to American Well's telemedicine services on MCMS' video-enabled platforms, and to allow bi-directional data flow between the two parties.

$JNJ {{ '2017-10-05T13:58:49+0000' | timeago}} • Announcement

Animas Corp., a $JNJ Diabetes Care Companies, plans to discontinue the manufacturing and sale of Animas Vibe and OneTouch Ping insulin pumps, close operations and exit the insulin pump business. Animas has selected $MDT as its partner-of-choice to facilitate a seamless transition for patients, caregivers and healthcare providers.

$HRC {{ '2017-10-05T12:06:47+0000' | timeago}} • Announcement

Chairman of $HRC Board Rolf Classon will not stand for re-election to the BoD when his current term expires on March 6, 2018. The Board plans to appoint current independent director William Dempsey to this role if he is re-elected by shareholders. The company also elected Gary Ellis, retired CFO and SVP of $MDT, to its BoD, effective Oct 5, 2017.

$AMAG {{ '2017-09-29T12:41:24+0000' | timeago}} • Announcement

$AMAG announced the appointment of Tracy Palmer Berns as Chief Compliance Officer, with immediate effect. She will report to Joseph Vittiglio, General Counsel and SVP of Legal Affairs and Quality. Berns was the VP of Ethics and Compliance at the Minimally Invasive Therapies Group at $MDT.

$MDT {{ '2017-09-18T13:29:52+0000' | timeago}} • Announcement

$MDT announced FDA approval and U.S. launch of the Intellis platform for the management of certain types of chronic intractable pain. The Intellis platform was designed to overcome limitations with current spinal cord stimulation (SCS) systems, such as battery performance, and can power the Evolve workflow.

$MDT {{ '2017-09-11T12:01:51+0000' | timeago}} • Announcement

$MDT voluntarily recalls specific lots of infusion sets used with all models of Medtronic insulin pumps due to a certain discontinued component. The recall comes after reports from patients that a component, the vent membrane, may be susceptible to being blocked by fluid during priming and fill-tubing, which can lead to over-delivery of insulin.

$MDT {{ '2017-09-08T11:44:21+0000' | timeago}} • Announcement

$MDT's IN.PACT Admiral Drug-Coated Balloon received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the treatment of peripheral artery disease in the upper leg. Before $MDT can begin commercialization, it must partner with Japanese MHLW to gain reimbursement to ensure broader access to this therapy.

$MDT {{ '2017-09-05T15:49:22+0000' | timeago}} • Announcement

$MDT launched a long-term clinical study of its INFUSE Bone Graft for use during Posterolateral Fusion (PLF) and Transforaminal Lumbar Interbody Fusion (TLIF) spine procedures. The first patient has been enrolled in the PLF study. The 10-year program is looking to enroll 550-700 individuals between the pilot and pivotal studies of both procedures.

$MDT {{ '2017-08-29T14:48:11+0000' | timeago}} • Webcast

On the IT disruption, $MDT said it is very difficult to separate and quantify the impact related to the outage. The company did say that the outage is not material to 1Q18 revenue or EPS, but stated that it is "very difficult to quantify beyond that."

$MDT {{ '2017-08-29T14:41:58+0000' | timeago}} • Webcast

$MDT said it is not really focused on transformative M&A, but will continue to have a disciplined approach to pursuing tuck-in acquisitions. Notably, the company is still in the last year of integration of Covidien.

$MDT {{ '2017-08-29T14:29:13+0000' | timeago}} • Webcast

$MDT's overall sensor unit demand has more than doubled in the past 10 quarters since launching the MiniMed 640G. The company now expects to see increasing revenue momentum from several new product launches over the balance of the fiscal year 2018.

$MDT {{ '2017-08-22T14:09:01+0000' | timeago}} • Announcement

$MDT maintains its FY18 earnings and revenue forecasts. The company sees non-GAAP EPS to increase 9-10% and revenue to increase 4-5% on a constant-currency basis.

$MDT {{ '2017-08-22T14:06:57+0000' | timeago}} • Announcement

On June, $MDT experienced an IT system disruption, impacting customer ordering, distribution, and manufacturing processes globally. The company said that the IT disruption did have some impact on the overall performance for 1Q18, but it was not material to revenue or earnings.

$MDT {{ '2017-08-22T14:00:40+0000' | timeago}} • Announcement

$MDT posted a 9.4% YoY increase in profit to $1.02Bil, or $0.74 per share, for 1Q18, as the medical device maker saw a strong demand for its heart and vascular devices. The Dublin-based company generated most of its sales from heart devices, spinal implants and insulin pumps, resulting in a 3.1% growth in revenue to $7.4Bil.

$MDT {{ '2017-08-22T12:50:12+0000' | timeago}} • Infographic

$MDT Medtronic plc Earnings AlphaGraphic: Q1 2018 Highlights

$CAH {{ '2017-07-31T12:06:51+0000' | timeago}} • Announcement

$CAH closed purchase of $MDT's Patient Care, Deep Vein Thrombosis and Nutritional Insufficiency business for $6.1Bil. The acquisition was funded with a combination of $4.5Bil in new senior unsecured notes, existing cash and borrowings under $CAH's existing credit arrangements.

$MDT {{ '2017-07-31T12:02:15+0000' | timeago}} • Announcement

$MDT completes the sale of its Patient Care, Deep Vein Thrombosis (Compression), and Nutritional Insufficiency businesses within the Patient Monitoring & Recovery division to $CAH for $6.1Bil in cash. The company expects modest dilution on a net basis to its FY18 non-GAAP EPS of approx. $0.18.

$LIVN {{ '2017-07-12T12:45:32+0000' | timeago}} • Announcement

$LIVN appointed Keyna Skeffington as SVP and General Counsel. Skeffington most recently served as Vice President of Legal – Corporate and Securities, Deputy General Counsel and Assistant Secretary at $MDT.

$MDT {{ '2017-07-10T15:43:07+0000' | timeago}} • Announcement

$MDT announced the expanded FDA approval of the self-expanding CoreValve Evolut transcatheter aortic valve replacement platform to include patients with symptomatic severe aortic stenosis who are at an intermediate risk for open-heart surgery.

Recent Transcripts

ELMD (Electromed, Inc.)
Wednesday, September 6 2017 - 1:00pm
MDT (Medtronic plc)
Tuesday, August 22 2017 - 12:00pm
RMTI (Rockwell Medical, Inc.)
Wednesday, August 9 2017 - 8:30pm
LIVN (LivaNova PLC)
Wednesday, August 9 2017 - 1:00pm
VCEL (Vericel Corporation)
Wednesday, August 9 2017 - 12:00pm
OMER (Omeros Corporation)
Tuesday, August 8 2017 - 8:30pm
ETRM (EnteroMedics Inc.)
Tuesday, August 8 2017 - 3:30pm
IRIX (IRIDEX Corporation)
Thursday, August 3 2017 - 9:00pm
TXMD (TherapeuticsMD, Inc.)
Thursday, August 3 2017 - 8:30pm
SYN (Synthetic Biologics Inc.)
Thursday, August 3 2017 - 12:30pm
AGN (Allergan plc)
Thursday, August 3 2017 - 12:30pm
CYTK (Cytokinetics, Incorporated)
Wednesday, August 2 2017 - 8:30pm
MASI (Masimo Corporation)
Wednesday, August 2 2017 - 8:30pm
TRXC (TransEnterix, Inc.)
Wednesday, August 2 2017 - 8:30pm
ROP (Roper Technologies, Inc.)
Monday, July 31 2017 - 12:30pm
HRC (Hill-Rom Holdings, Inc.)
Friday, July 28 2017 - 12:30pm
BMY (Bristol-Myers Squibb Company)
Thursday, July 27 2017 - 2:30pm
CELG (Celgene Corporation)
Thursday, July 27 2017 - 1:00pm
VAR (Varian Medical Systems, Inc.)
Wednesday, July 26 2017 - 9:00pm
GILD (Gilead Sciences Inc.)
Wednesday, July 26 2017 - 8:30pm

AlphaGraphics you may like